Insider · CIK 0001251213

Bentsur RON

CIK 0001251213 Name as filed on the most recent filing

Filed as Bentsur RON (96)

155 transaction lines · from 96 filings · filed 2006-03-31 to 2026-07-01 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

155 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-08-18 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 123,775, acquired Open Form 4 filing 0001104659-22-093128
2022-08-11 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 165,220, acquired Open Form 4 filing 0001104659-22-091746
2022-06-30 S, Open-market sale Beyond Air, Inc.XAIR 261,104, disposed Open Form 4 filing 0001493152-22-018552
2022-06-29 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 42,994, acquired Open Form 4 filing 0001104659-22-076049
2022-06-28 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 3,546, acquired Open Form 4 filing 0001104659-22-076049
2022-06-24 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 4,872, acquired Open Form 4 filing 0001104659-22-074544
2022-06-23 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 2,280, acquired Open Form 4 filing 0001104659-22-074544
2022-06-22 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 1,310, acquired Open Form 4 filing 0001104659-22-074544
2022-05-27 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 7,870, acquired Open Form 4 filing 0001104659-22-066269
2022-05-26 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 7,950, acquired Open Form 4 filing 0001104659-22-066269
2022-05-20 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 16,280, acquired Open Form 4 filing 0001104659-22-063645
2022-05-19 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 3,790, acquired Open Form 4 filing 0001104659-22-063645
2022-05-18 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 2 lines 32,910, acquired Open Form 4 filing 0001104659-22-062766
2022-05-17 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 2 lines 6,245, acquired Open Form 4 filing 0001104659-22-062766
2022-05-16 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 19,320, acquired Open Form 4 filing 0001104659-22-061753
2022-05-13 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 12,670, acquired Open Form 4 filing 0001104659-22-061753
2022-05-12 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 3 lines 208,047, acquired Open Form 4 filing 0001104659-22-059888
2022-03-28 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 28,200, acquired Open Form 4 filing 0001104659-22-039119
2022-03-17 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 53,410, acquired Open Form 4 filing 0001104659-22-035347
2022-02-14 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 47,040, acquired Open Form 4 filing 0001104659-22-023547
2022-02-10 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 53,890, acquired Open Form 4 filing 0001104659-22-019955
2022-02-07 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 2 lines 104,520, acquired Open Form 4 filing 0001104659-22-013142
2022-02-04 P, Open-market purchase Nuvectis Pharma, Inc.NVCT 2 lines 1,048,625, acquired Open Form 4 filing 0001104659-22-013142
2021-11-24 S, Open-market sale Beyond Air, Inc.XAIR 2 lines 507,071, disposed Open Form 4 filing 0001493152-21-029937
2021-02-12 S, Open-market sale Beyond Air, Inc.XAIR 148,945, disposed Open Form 4 filing 0001493152-21-004261
2021-02-11 S, Open-market sale Beyond Air, Inc.XAIR 9,420, disposed Open Form 4 filing 0001493152-21-004261
2021-01-02 S, Open-market sale Beyond Air, Inc.XAIR 33,573, disposed Open Form 4 filing 0001493152-21-003005
2020-08-25 S, Open-market sale Beyond Air, Inc.XAIR 9,406, disposed Open Form 4 filing 0001493152-20-016856
2020-08-24 S, Open-market sale Beyond Air, Inc.XAIR 22,104, disposed Open Form 4 filing 0001493152-20-016710
2020-08-21 S, Open-market sale Beyond Air, Inc.XAIR 19,651, disposed Open Form 4 filing 0001493152-20-016710
2020-08-20 S, Open-market sale Beyond Air, Inc.XAIR 23,780, disposed Open Form 4 filing 0001493152-20-016525
2020-08-19 S, Open-market sale Beyond Air, Inc.XAIR 41,266, disposed Open Form 4 filing 0001493152-20-016525
2020-08-18 S, Open-market sale Beyond Air, Inc.XAIR 26,691, disposed Open Form 4 filing 0001493152-20-016331
2020-08-17 S, Open-market sale Beyond Air, Inc.XAIR 25,226, disposed Open Form 4 filing 0001493152-20-016211
2020-08-14 S, Open-market sale Beyond Air, Inc.XAIR 36,932, disposed Open Form 4 filing 0001493152-20-016122
2020-08-13 S, Open-market sale Beyond Air, Inc.XAIR 22,494, disposed Open Form 4 filing 0001493152-20-015976
2020-08-12 S, Open-market sale Beyond Air, Inc.XAIR 24,834, disposed Open Form 4 filing 0001493152-20-015547
2020-08-11 S, Open-market sale Beyond Air, Inc.XAIR 21,553, disposed Open Form 4 filing 0001493152-20-015399
2020-08-10 S, Open-market sale Beyond Air, Inc.XAIR 18,636, disposed Open Form 4 filing 0001493152-20-015399
2020-08-07 S, Open-market sale Beyond Air, Inc.XAIR 54,657, disposed Open Form 4 filing 0001493152-20-015135
2020-08-06 S, Open-market sale Beyond Air, Inc.XAIR 36,777, disposed Open Form 4 filing 0001493152-20-015015
2020-08-05 S, Open-market sale Beyond Air, Inc.XAIR 22,286, disposed Open Form 4 filing 0001493152-20-015015
2020-08-04 S, Open-market sale Beyond Air, Inc.XAIR 22,369, disposed Open Form 4 filing 0001493152-20-014877

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 91
  • Open-market sale 64
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. BENTSUR RON, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001251213

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.